MCK official logo MCK
MCK 3-star rating from Upturn Advisory
McKesson Corporation (MCK) company logo

McKesson Corporation (MCK)

McKesson Corporation (MCK) 3-star rating from Upturn Advisory
$813.8
Last Close (24-hour delay)
Profit since last BUY5.01%
upturn advisory logo
SELL
SELL since 5 days
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock price based on last close icon Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • 1Y
  • 1M
  • 1W

Upturn Advisory Summary

12/12/2025: MCK (3-star) is a SELL. SELL since 5 days. Simulated Profits (5.01%). Updated daily EoD!

Upturn Star Rating

Upturn 3 star rating for performance

Moderate Performance

These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.

Number of Analysts

3 star rating from financial analysts

17 Analysts rated it

Moderately tracked stock, growing coverage, gaining market and investor attention.

1 Year Target Price $939.33

1 Year Target Price $939.33

Analysts Price Target For last 52 week
$939.33 Target price
52w Low $555.78
Current$813.8
52w High $894.75

Analysis of Past Performance

Type Stock
Historic Profit 50.34%
Avg. Invested days 72
Today’s Advisory SELL
Upturn Star Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 4.0
Stock Returns Performance Upturn Returns Performance icon 3.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 12/12/2025

Key Highlights

Company Size Large-Cap Stock
Market Capitalization 101.22B USD
Price to earnings Ratio 25.45
1Y Target Price 939.33
Price to earnings Ratio 25.45
1Y Target Price 939.33
Volume (30-day avg) 17
Beta 0.38
52 Weeks Range 555.78 - 894.75
Updated Date 12/14/2025
52 Weeks Range 555.78 - 894.75
Updated Date 12/14/2025
Dividends yield (FY) 0.36%
Basic EPS (TTM) 31.98

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 1.04%
Operating Margin (TTM) 1.37%

Management Effectiveness

Return on Assets (TTM) 4.78%
Return on Equity (TTM) -

Valuation

Trailing PE 25.45
Forward PE 18.59
Enterprise Value 106232607770
Price to Sales(TTM) 0.26
Enterprise Value 106232607770
Price to Sales(TTM) 0.26
Enterprise Value to Revenue 0.27
Enterprise Value to EBITDA 17.5
Shares Outstanding 123426650
Shares Floating 123257555
Shares Outstanding 123426650
Shares Floating 123257555
Percent Insiders 0.03
Percent Institutions 90.77

About McKesson Corporation

Exchange NYSE
Headquaters Irving, TX, United States
IPO Launch date 1994-11-15
CEO & Director Mr. Brian S. Tyler Ph.D.
Sector Healthcare
Industry Medical Distribution
Full time employees 43000
Full time employees 43000

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners to address challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver solutions to help people get the medicine needed to live healthier lives; and provides medication access and affordability, prescription decision support, prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services, as well as electronic prior authorization services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, biomedical maintenance, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, post-acute care facilities, hospital reference labs, and home health care agencies. The International segment delivers medicines, supplies, and information technology solutions to retail pharmacies, hospitals, long-term care centers, clinics and institutions; and provides logistics and distribution services for manufacturers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.